Practice Alert Podcast

Study offers reassurance to postmenopausal women taking hormone therapy

J Fam Pract. 2020 October;69(8):audio
Author(s):
Doug Campos-Outcalt, MD, MPA
Author and Disclosure Information

This month, Dr. Campos-Outcalt summarizes findings from a long-term follow-up study of Women’s Health Initiative participants that offers reassurance for women who use hormone therapy to relieve postmenopausal symptoms. He also describes how the study’s findings lend further support to a US Preventive Services Task Force recommendation against using hormone therapy for the prevention of chronic conditions.

 

References

  1. Chlebowski RT, Anderson GL, Aragaki AK, et al. Association of menopausal hormone therapy with breast cancer incidence and mortality during long-term follow-up of the Women’s Health Initiative randomized clinical trials. JAMA. 2020;32:369-380.
  2. The North American Menopause Society. Menopause Guidebook. 8th ed. www.menopause.org/publications/consumer-publications/-em-menopause-guidebook-em-8th-edition. Accessed September 25, 2020.
  3. US Preventive Services Task Force; Grossman DC, Curry SJ, Owens DK, et al. Hormone therapy for the primary prevention of chronic conditions in postmenopausal women: US Preventive Services Task Force Recommendation Statement. JAMA. 2017;318:2224-2233.

Next Article:

Three-step approach may help relieve one of the itchiest vulvar conditions